X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3834) 3834
Publication (232) 232
Book Review (33) 33
Magazine Article (10) 10
Book Chapter (4) 4
Paper (4) 4
Data Set (2) 2
Conference Proceeding (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3103) 3103
atorvastatin calcium (2558) 2558
male (2392) 2392
pyrroles - therapeutic use (2259) 2259
heptanoic acids - therapeutic use (2257) 2257
female (2039) 2039
index medicus (2013) 2013
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (1879) 1879
atorvastatin (1818) 1818
middle aged (1802) 1802
statins (1371) 1371
aged (1329) 1329
anticholesteremic agents - therapeutic use (1001) 1001
treatment outcome (936) 936
adult (881) 881
cholesterol (865) 865
cardiac & cardiovascular systems (755) 755
pharmacology & pharmacy (719) 719
animals (702) 702
cholesterol, ldl - blood (702) 702
simvastatin (700) 700
risk factors (567) 567
heptanoic acids - pharmacology (554) 554
pyrroles - pharmacology (554) 554
hypercholesterolemia - drug therapy (534) 534
atherosclerosis (515) 515
simvastatin - therapeutic use (505) 505
pyrroles - administration & dosage (464) 464
heptanoic acids - administration & dosage (463) 463
lipids (449) 449
pravastatin (438) 438
risk (422) 422
rosuvastatin calcium (417) 417
double-blind method (410) 410
rosuvastatin (410) 410
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (407) 407
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (406) 406
prevention (396) 396
drug therapy, combination (387) 387
drug therapy (384) 384
hypercholesterolemia (384) 384
prospective studies (382) 382
inflammation (378) 378
medicine, general & internal (377) 377
cardiovascular disease (364) 364
fluorobenzenes - therapeutic use (355) 355
antilipemic agents (347) 347
sulfonamides - therapeutic use (345) 345
therapy (345) 345
coronary-heart-disease (341) 341
pyrimidines - therapeutic use (339) 339
care and treatment (338) 338
peripheral vascular disease (338) 338
research (336) 336
analysis (333) 333
cholesterol - blood (332) 332
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (332) 332
dose-response relationship, drug (327) 327
c-reactive protein (326) 326
rats (324) 324
statin (319) 319
pyrroles - adverse effects (317) 317
heptanoic acids - adverse effects (316) 316
time factors (316) 316
disease (314) 314
atorvastatin calcium - therapeutic use (298) 298
lipids - blood (290) 290
pravastatin - therapeutic use (286) 286
triglycerides - blood (282) 282
cardiovascular (281) 281
cardiovascular-disease (267) 267
cholesterol, hdl - blood (267) 267
cardiovascular diseases (259) 259
aged, 80 and over (258) 258
statin therapy (258) 258
hyperlipidemias - drug therapy (252) 252
mortality (252) 252
cardiovascular agents (247) 247
follow-up studies (246) 246
myocardial-infarction (246) 246
abridged index medicus (245) 245
cardiovascular diseases - prevention & control (242) 242
coronary heart disease (239) 239
biomarkers - blood (235) 235
hypercholesterolemia - blood (235) 235
efficacy (226) 226
mice (226) 226
dyslipidemias - drug therapy (225) 225
low density lipoproteins (219) 219
diabetes (217) 217
randomized controlled trials as topic (211) 211
medicine (209) 209
safety (208) 208
anticholesteremic agents - administration & dosage (203) 203
health aspects (203) 203
dosage and administration (200) 200
hypolipidemic agents - therapeutic use (200) 200
hypertension (199) 199
cardiology (197) 197
oxidative stress (197) 197
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3604) 3604
German (57) 57
Chinese (49) 49
Russian (42) 42
Spanish (29) 29
French (20) 20
Japanese (12) 12
Italian (9) 9
Polish (6) 6
Hungarian (5) 5
Turkish (4) 4
Ukrainian (4) 4
Czech (2) 2
Dutch (2) 2
Portuguese (2) 2
Danish (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 3, pp. 520 - 532
Journal Article
European heart journal, ISSN 0195-668X, 2017, Volume 38, Issue 42, pp. 3124 - 3134
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 253, pp. 194 - 208
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158608
Purpose To examine HMG-CoA reductase inhibitor (statin) drug dispensing patterns to Nova Scotia Seniors' Pharmacare program (NSSPP) beneficiaries over a... 
C-REACTIVE PROTEIN | THERAPY | CHOLESTEROL | MULTIDISCIPLINARY SCIENCES | CARDIOVASCULAR-DISEASE | JUPITER TRIAL | PEOPLE | HEALTH | RISK-ASSESSMENT | PRIMARY PREVENTION | ROSUVASTATIN | Simvastatin - therapeutic use | Rosuvastatin Calcium - therapeutic use | Humans | Male | Lovastatin - supply & distribution | Atorvastatin Calcium - supply & distribution | Indoles - supply & distribution | Fatty Acids, Monounsaturated - therapeutic use | Aged, 80 and over | Female | Prescription Drugs - supply & distribution | Retrospective Studies | Pravastatin - therapeutic use | Atorvastatin Calcium - therapeutic use | Lovastatin - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Interrupted Time Series Analysis | Clinical Trials as Topic | Hypolipidemic Agents - supply & distribution | Simvastatin - supply & distribution | Health Knowledge, Attitudes, Practice | Pravastatin - supply & distribution | Prescription Drugs - therapeutic use | Nova Scotia | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Indoles - therapeutic use | Aged | Hypolipidemic Agents - therapeutic use | Fatty Acids, Monounsaturated - supply & distribution | Rosuvastatin Calcium - supply & distribution | Economic aspects | Aged patients | Care and treatment | Dosage and administration | Laws, regulations and rules | Statins | Availability | Time series analysis | Simvastatin | Time series | Dispensing | Data processing | Lovastatin | Cardiovascular disease | Insurance coverage | Pravastatin | Confidence intervals | Studies | Prescription drugs | Fluvastatin | Pharmacy | Atorvastatin | Population | Hydroxymethylglutaryl-CoA reductase | Trends | Pharmaceutical industry
Journal Article
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 764, pp. 283 - 291
The present study was carried out to evaluate the protective effect of different statins on isoproterenol (ISO) induced myocardial necrosis. Atorvastatin,... 
Fluvastatin | Simvastatin | Atorvastatin | Rosuvastatin | Myocardial necrosis | Isoproterenol | Pravastatin | CHRONIC HEART-FAILURE | COENZYME-A REDUCTASE | CHOLESTEROL | INFARCTION | PLASMA | PHARMACOLOGY & PHARMACY | RAT-HEART | LIPOPROTEINS | STATIN TREATMENT | Necrosis - drug therapy | Myocardial Infarction - chemically induced | Simvastatin - therapeutic use | Fatty Acids, Monounsaturated - pharmacology | Rosuvastatin Calcium - therapeutic use | Rats, Wistar | Atorvastatin Calcium - pharmacology | Glutathione - metabolism | Cholesterol - blood | Male | Simvastatin - pharmacology | Necrosis - pathology | Cardiotonic Agents - therapeutic use | Fatty Acids, Monounsaturated - therapeutic use | Myocardial Infarction - pathology | Myocardium - metabolism | Indoles - pharmacology | Pravastatin - therapeutic use | Atorvastatin Calcium - therapeutic use | Superoxide Dismutase - metabolism | Pravastatin - pharmacology | Blood Glucose - analysis | Rosuvastatin Calcium - pharmacology | Adenosine Triphosphatases - metabolism | Myocardium - pathology | Necrosis - metabolism | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Necrosis - chemically induced | Catalase - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Myocardial Infarction - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Isoproterenol - pharmacology | Triglycerides - blood | Indoles - therapeutic use | Isoproterenol - therapeutic use | Antioxidants | Pharmacy | Drugstores | Glucose | Comparative analysis | Statins | Dextrose | Necrosis
Journal Article
Diabetes, ISSN 0012-1797, 02/2017, Volume 66, Issue 2, pp. 347 - 357
MicroRNA-122 (miR-122) is abundant in the liver and involved in lipid homeostasis, but its relevance to the long-term risk of developing metabolic disorders is... 
MIR-122 | LIPID-METABOLISM | PLASMA | INSULIN-RESISTANCE | IN-VIVO | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | DENSITY-LIPOPROTEINS | OUTCOMES | PRIMATES | BRUNECK | Multivariate Analysis | Prevalence | Prospective Studies | Atorvastatin Calcium - pharmacology | Humans | Middle Aged | Glycoproteins - metabolism | Male | Metabolic Syndrome - metabolism | MicroRNAs - metabolism | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Serum Albumin, Human | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Oligonucleotides - pharmacology | Mass Spectrometry | Adult | Female | Real-Time Polymerase Chain Reaction | Atorvastatin Calcium - therapeutic use | Hepatocytes - drug effects | Metabolic Syndrome - epidemiology | Dyslipidemias - drug therapy | Insulin Resistance | Lipid Metabolism | Reverse Transcriptase Polymerase Chain Reaction | Obesity - metabolism | Blotting, Northern | Animals | Carrier Proteins - metabolism | Complement Factor H - metabolism | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipoproteins, VLDL - metabolism | Obesity - epidemiology | MicroRNAs - drug effects | Dyslipidemias - metabolism | Aged | Mice | Serum Albumin - metabolism | Type 2 diabetes | MicroRNA | Analysis | Research | Metabolic syndrome X | Risk factors | Public health | Metabolism
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2017, Volume 40, Issue 8, pp. 1247 - 1254
Journal Article
Medicine, ISSN 0025-7974, 08/2018, Volume 97, Issue 31, p. e11718
Journal Article